The Patent Finder
SG

Singular Genomics Systems, Inc.

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

141 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2037. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Nov 2037
Next term end
67
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Methods for in Situ Transcriptomics and Proteomics US 11,643,679
Cited by 27 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2041.
Ends Aug 2041 · High confidence
Also notable
Spatial Sequencing US 11,434,525
Cited by 34 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2041.
Ends Aug 2041 · High confidence
Also notable
Linked Paired Strand Sequencing US 11,359,238
Cited by 17 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2041.
Ends Mar 2041 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 20 to 27, 2026 · next Dec 20
  • 1 fee due Jan 11, 2027
    The maintenance fee for Silicon Containing Detectable Compounds (US 11,697,736) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
  • 1 fee due Feb 1, 2027
    The maintenance fee for Methods and Systems for Multidimensional Imaging (US 11,714,271) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
  • 2 fees due Mar 5 to 12, 2027 · next Mar 5
  • 4 fees due Apr 3 to 30, 2027 · next Apr 3
  • 1 fee due May 14, 2027
    The maintenance fee for Flow Cell Receiver and Devices (US 11,813,615) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jun 19, 2027
    The maintenance fee for Modified Archaeal Family B Polymerases (US 11,845,923) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
  • 4 fees due Jul 2 to 30, 2027 · next Jul 2
  • 4 fees due Aug 6 to 27, 2027 · next Aug 6
  • 1 fee due Sep 19, 2027
    The maintenance fee for Amplification Oligonucleotides (US 11,932,905) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
  • 4 fees due Oct 2 to 30, 2027 · next Oct 2

Which patents, and when each one lapses · Pro

Recent changes

  • 6 of the patents on this record were granted since Aug 23, 2026

What they patent

The largest of its 67 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US D970,036Reagent Cartridge
In force
 · High confidence
In forceHigh confidence
US D970,748Wash Bottle
In force
 · High confidence
In forceHigh confidence
US D979,093Reagent Cartridge
In force
 · High confidence
In forceHigh confidence
US 11,773,439Nucleic Acid Sequencing-By-Synthesis (SBS) Methods That Combine SBS Cycle Steps
In force
 · High confidence
In forceHigh confidence
US 12,790,644Sequencing methods that combine imaging and extension
In force
 · High confidence
In forceHigh confidence
US D981,591Sample Cartridge
In force
 · High confidence
In forceHigh confidence
US D983,404Flow Cell Carrier
In force
 · High confidence
In forceHigh confidence
US 10,954,551Devices, Systems, and Methods for Single Molecule, Real-Time Nucleic Acid Sequencing
In force
 · High confidence
In forceHigh confidence
US D1,001,310Strip Tube for a Reagent Cartridge
In force
 · High confidence
In forceHigh confidence
US D1,005,517Sample Cartridge
In force
 · High confidence
In forceHigh confidence
10 of 141 patents shown.
Pro members see all 141.
Pro members: see all 141 patents
Also on record, not counted in the 141: 4 patents ended · 122 applications pending · 9 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited